Histamine 2 receptors in cardiovascular biology: A friend for the heart

Sherin Saheera1, Ajay Godwin Potnuri1, Ashrith Guha2

  • 1Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.

Drug Discovery Today
|August 26, 2021
PubMed

Insights

Investigating histamine and its receptors in cardiovascular diseases (CVDs) reveals their role in cardiac hypertrophy. Targeting histamine 2 receptors (H2Rs) with antagonists may improve heart function and offer new therapeutic strategies.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) involve complex mediators, including inflammation and mast cells.
  • Mast cell mediators, particularly histamine, significantly influence cardiac pathophysiology.
  • Hypertension-induced cardiac hypertrophy is linked to histamine and its effects on the heart.

Purpose of the Study:

  • To review mast cell activation, mediators, and histamine receptors in cardiovascular diseases.
  • To focus on the role of histamine 2 receptors (H2Rs) in cardiac anomalies.
  • To explore the therapeutic potential of targeting histamine receptors for CVD management.

Main Methods:

  • Review of preclinical and clinical studies.
  • Analysis of the impact of histamine and its receptors on cardiac function.
  • Examination of studies involving histamine receptor antagonists.

Main Results:

  • Histamine and its receptors play a profound role in the development of cardiac hypertrophy and other cardiac issues.
  • Histamine receptor antagonists have demonstrated improvements in cardiac function in studies.
  • Mast cells and their mediators are critical players in cardiovascular disease progression.

Conclusions:

  • Understanding histamine receptor function is key to developing novel CVD therapies.
  • Antihistamines may be repurposed for treating cardiovascular diseases.
  • Targeting mast cell mediators offers a promising avenue for managing cardiac conditions.

Related Concept Videos

Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.4K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
186
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
108
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.3K
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
2.8K